BiotechTube
Home/DiaMedica Therapeutics/Scott Kellen
SK

Scott Kellen

Chief Executive Officer

DiaMedica Therapeutics

Therapeutic Areas

Obstetrics & GynecologyNeurologyNephrology

DiaMedica Therapeutics Pipeline

DrugIndicationPhase
DM199 (rinvecalinase alfa)Preeclampsia (PE)Phase 2

Leadership Team at DiaMedica Therapeutics

RP
Rick Pauls
President & Chief Operating Officer
V(
Veronica (Ronnie) Jenkins
Chief Financial Officer
HA
Harry Alcorn
Chief Medical Officer
K(
Katherine (Kate) Rielly
General Counsel
View full DiaMedica Therapeutics profile